Skip to main content
HR 5145 114th Congress House Health Child health Drug trafficking and controlled substances Drug, alcohol, tobacco use Fraud offenses and financial crimes Freedom of information Government information and archives Government studies and investigations Health care costs and insurance Health information and medical records Health programs administration and funding Medicaid Medicare Prescription drugs Public contracts and procurement

To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs,…

Show full title

To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes.

Introduced: April 29, 2016 Introduced by: Bilirakis, Gus M. Republican · Florida See on congress.gov
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 17, 2016
Referred to the Subcommittee on Health.
May 6, 2016
Referred to the Subcommittee on Health.
Apr 29, 2016
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 29, 2016
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill amends title XIX (Medicaid) of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the requirement that manufacturers of single-source or innovator drugs pay additional rebates to state Medicaid programs.

Under current law, the Centers for Medicare & Medicaid Services (CMS) must use predictive modeling and other analytic technologies to identify improper Medicaid claims. The bill prohibits a state agency from using or disclosing such technologies except for purposes of administering a state Medicaid program or Children's Health Insurance Program (CHIP). A state agency shall have in effect adequate data security and control policies to ensure that access to such information is restricted to authorized persons for authorized uses.

The bill places $5 million in the Medicaid Improvement Fund to be available beginning in FY2021.

What's happening now May 17, 2016

Referred to the Subcommittee on Health.

 Related & companion bills 3
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5145: To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes.. 114th Congress. Open America. https://openamerica.io/bill/114-HR-5145/
MLA
"H.R. 5145: To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes.." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-5145/.
Bluebook (legal)
H.R. 5145, 114th Cong. (2026), https://openamerica.io/bill/114-HR-5145/.
Markdown link
[H.R. 5145: To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes.](https://openamerica.io/bill/114-HR-5145/)
Report a problem